TET Enzymes as Epigenetic Integrators in Intestinal Immunity, Inflammation, and Disease
Journal of Personalized Medicine · 14.07.2026 · 16 (7) · 375
DOI: 10.3390/jpm16070375 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 14.07.2026. Verfasst von Dhirendra K Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Inflammation Research, University of Gothenburg, 40530 Gothenburg, Sweden. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
DNA methylation plays a fundamental role in maintaining intestinal homeostasis, immune tolerance, and inflammatory balance. Active DNA demethylation, mediated by the ten-eleven translocation family of dioxygenases (TET1, TET2, and TET3), has emerged as an important epigenetic mechanism linking environmental and metabolic cues to gene regulatory programs in the gut. In the intestinal epithelium, TET-dependent DNA hydroxymethylation contributes to intestinal stem cell maintenance, epithelial differentiation, regeneration, and barrier integrity. Perturbations in TET activity are associated with epithelial dysfunction, chronic inflammation, and increased susceptibility to colorectal tumorigenesis. Within the immune compartment, TET-mediated demethylation is required for the epigenetic stabilization of gut-associated immune cells. Altered TET function has been implicated in immune imbalance in inflammatory bowel disease, Hirschsprung’s disease, and colitis-associated colorectal cancer. Emerging evidence further indicates that intestinal microbiota-derived metabolites, including short-chain fatty acids and aryl hydrocarbon receptor ligands, modulate TET activity, positioning TET enzymes as epigenetic sensors of microbial and metabolic signals. In turn, TET-dependent programs shape immune responses to commensal microbes and pathogens, establishing a bidirectional microbiota–epigenetic axis that influences both intestinal and systemic immunity. In this review, we summarize and critically evaluate current evidence on the roles of TET enzymes in intestinal epithelial biology, immune cell regulation, and host–microbiota interactions in colorectal inflammation and disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rheumatology and Inflammation Research, University of Gothenburg, 40530 Gothenburg, Sweden.
- Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
- Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
- Department of Biology, American University, Washington, DC 20016, USA.
- Laboratory of Animal Food Function, School of Agricultural Science, Tohoku University, Sendai 980-8572, Japan.
ORCID-Profile: Lei Huang, Chieko Saito
Zitieren
APA
Singh, D. K., Yamaguchi, Y., Huang, L., Saito, C., Cassidy, O. G., & Nishiyama, K. (2026). TET Enzymes as Epigenetic Integrators in Intestinal Immunity, Inflammation, and Disease. Journal of Personalized Medicine, 16(7), 375. https://doi.org/10.3390/jpm16070375
Vancouver
Singh DK, Yamaguchi Y, Huang L, Saito C, Cassidy OG, Nishiyama K. TET Enzymes as Epigenetic Integrators in Intestinal Immunity, Inflammation, and Disease. Journal of Personalized Medicine. 2026;16(7):375. doi:10.3390/jpm16070375
BibTeX
@article{Singh2026,
author = {Singh, Dhirendra K and Yamaguchi, Yukihiro and Huang, Lei and Saito, Chieko and Cassidy, Olivia G and Nishiyama, Keita},
title = {TET Enzymes as Epigenetic Integrators in Intestinal Immunity, Inflammation, and Disease},
journal = {Journal of Personalized Medicine},
year = {2026},
volume = {16},
number = {7},
pages = {375},
doi = {10.3390/jpm16070375}
}
EUVIMED